Vir Biotechnology

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. 

CEO
George A. Scangos
CEOGeorge A. Scangos
Employees
444
Employees444
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2016
Founded2016
Employees
444
Employees444

VIR Key Statistics

Market cap
2.47B
Market cap2.47B
Price-Earnings ratio
2.32
Price-Earnings ratio2.32
Dividend yield
Dividend yield
Average volume
1.53M
Average volume1.53M
High today
$18.70
High today$18.70
Low today
$18.05
Low today$18.05
Open price
$18.34
Open price$18.34
Volume
1.76M
Volume1.76M
52 Week high
$58.00
52 Week high$58.00
52 Week low
$18.05
52 Week low$18.05

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
37.5%
Sell
0%

VIR Earnings

-$1.32
$0.43
$2.17
$3.92
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.